Biogen | BIIB - Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Biogen

Biogen reported $24.6B in Assets for its fiscal quarter ending in March of 2023.


Assets Change
Acadia Pharmaceuticals ACAD:US USD 655.3M 67.49M
Acorda Therapeutics ACOR:US USD 374.91M 20.69M
ALKERMES ALKS:US USD 1.92B 41.25M
Amgen AMGN:US USD 88.72B 23.6B
Bayer BAYN:GR EUR 125.05B 175M
Biogen BIIB:US USD 24.6B 44.3M
BioMarin Pharmaceutical BMRN:US USD 6.43B 58.62M
Bluebird Bio BLUE:US USD 692.74M 137.83M
Eli Lilly LLY:US USD 53.16B 3.67B
Esperion Therapeutics ESPR:US USD 251.82M 3.88M
Gilead Sciences GILD:US USD 61.88B 1.3B
Incyte Corp INCY:US USD 5.8B 43.36M
Intercept Pharmaceuticals ICPT:US USD 504.08M 49.63M
Intra Cellular Therapies ITCI:US USD 722.16M 32.62M
Marinus Pharmaceuticals MRNS:US USD 226.82M 32.7M
Moderna Inc MRNA:US USD 24.12B 1.73B
Neurocrine Biosciences NBIX:US USD 2.36B 8.9M
Novartis NOVN:VX USD 112.24B 5.21B
PTC Therapeutics PTCT:US USD 1.61B 96.78M
Puma Biotechnology PBYI:US USD 196.26M 25.8M
Regeneron Pharmaceuticals REGN:US USD 30.06B 845.4M
Sangamo BioSciences SGMO:US USD 440.57M 121.94M
Sarepta Therapeutics SRPT:US USD 3.06B 68.58M
Seattle Genetics SGEN:US USD 3.54B 131.24M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 43.46B 550M
Ultragenyx Pharmaceutical RARE:US USD 1.38B 162.04M
United Therapeutics UTHR:US USD 6.35B 301.5M
Vertex Pharmaceuticals VRTX:US USD 18.97B 823.3M